Oncolys BioPharma Inc.
Oncolys BioPharma Inc. (JPX: 4588) is trading at ¥5,920.00, about ₹3,613 at today's JPY/INR rate, as of 29 Sep 2026, 8:40 PM ET, up 5.15% today. Indian residents can buy Oncolys BioPharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥5,540.00
Today's high
¥5,960.00
52 week low
¥623.00
52 week high
¥6,850.00
4588 opened at ¥5,630.00, closed previously at ¥5,630.00, and has traded between ¥623.00 and ¥6,850.00 over the past 52 weeks.
About
Oncolys BioPharma Inc. is a biotechnology firm dedicated to the research, development, manufacturing, sales, and distribution of oncolytic viruses, pharmaceutical drugs, and diagnostic agents for tumors across Japan, other Asian regions, and the United States. Its robust pipeline features Telomelysin (OBP-301), an oncolytic adenovirus, currently in Phase II clinical trials for the treatment of gastric, gastroesophageal junction, head and neck, and esophageal cancers, and in Phase I trials for hepatocellular carcinoma. Other key developments include OBP-702, a telomerase-specific oncolytic adenovirus in preclinical stages for solid tumors; OBP-2011, also preclinical, targeting SARS-CoV-2 infection; OBP-601 (Censavudine), a nucleotide reverse transcriptase inhibitor that has completed Phase IIb clinical trials for HIV; and OBP-801, a histone deacetylase inhibitor, which is in Phase I clinical trials for solid tumors and preclinical assessment for ophthalmic applications. Additionally, the company is advancing TelomeScan (OBP-401 and OBP-1101), a cancer detection drug designed to identify living circulating tumor cells in cancer patients' blood. Oncolys BioPharma also offers diagnostic medications and inspection services. The company boasts various licensing and collaborative agreements with institutions such as Okayama University, Osaka University, Kyoto Prefectural University of Medicine, Kagoshima University, Astellas Pharma Inc., Yale University, Biologics Consulting Group, Inc., Lonza Houston, Inc., Medigen Biotechnology Corp., and Liquid Biotech USA, Inc. Founded in 2004, Oncolys BioPharma Inc. is based in Tokyo, Japan.
Key statistics
Avg. volume
1.46M
Market cap
¥173.36B
P/E Ratio
-107.71
Price-to-sales ratio
344.58
Enterprise value
¥32.25B
Free cash flow yield
-5.46%
Debt-to-equity ratio
0.25
Return on equity
-51.45%
ROIC
-46.76%
Beta
1.19
Dividend yield
0.00%
Last dividend
¥0.00
Financial overview
Revenue
¥28.55M
Earnings per share
-¥80.00
Free cash flow
-¥1.94B
Net profit margin
-299.54%
Gross margin
99.95%
EBITDA
-¥2.05B
Revenue growth
-9.04%
Similar securities
This is not an investment recommendation
How to buy Oncolys BioPharma from India
Indian residents can buy Oncolys BioPharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for Oncolys BioPharma and place an order
Find Oncolys BioPharma by name or by its ticker, 4588, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Oncolys BioPharma trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Oncolys BioPharma position in JPY and INR. Oncolys BioPharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Oncolys BioPharma from India
Trading and taxes when buying Oncolys BioPharma from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneOncolys BioPharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Oncolys BioPharma stock?
Yes. Oncolys BioPharma (4588) has been listed on the Tokyo Stock Exchange since 2013, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Oncolys BioPharma share cost in rupees?
One Oncolys BioPharma share is ¥5,920.00 — about ₹3,613 at a JPY/INR rate of 0.6103 on 29 Sep 2026. Both the Oncolys BioPharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Oncolys BioPharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Oncolys BioPharma?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on Oncolys BioPharma shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Oncolys BioPharma price. Paasa issues a capital-gains statement for your return.
Does Oncolys BioPharma pay a dividend?
No. Oncolys BioPharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Oncolys BioPharma from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Oncolys BioPharma shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare Oncolys BioPharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Oncolys BioPharma holding, its cost and its closing value.
How do I sell Oncolys BioPharma and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.